Skip to main content

Case Studies

Workflow study outputs highlighting qualitative and quantitative evidence.

Leica Biosystems team of clinical and process experts conducted on site observations of processes, from the time a patient entered the biopsy suite, until the time their pathology report with diagnosis was delivered.

There is a paradigm shift in breast biopsy philosophy. In the past radiologists and clinicians used to collect as little tissue as possible for pathologists to render a diagnosis on conventional histologic H&E sections.

Histopathologic examination of adequate, minimally invasive breast core biopsy samples corresponding to an abnormal radiological finding is the standard of care prior to any therapeutic intervention or mammographic surveillance decision.

Want us to feature your writing?
We are looking for more great writers to feature here. Send us a submission and we’ll be in touch!
Like what you see?
Get more Knowledge Pathway content delivered directly to your inbox. Unsubscribe at any time.